Moreover, HRE luciferase activity, indicated HIF-1α DNA binding ability, was enhanced in HMGB1 treated CD133− cancer cells and suppressed in the presence of EP under hypoxia (Fig. 5d). The gene discussed is HMGB1; the disease is cancer.